One such molecule is endocan (endothelial cell‐specific molecule‐1 [ESM‐1]), which is indeed a potential immunoinflammatory marker that is related with cardiovascular disease as well as tumor angiogenesis (Matano et al. 2014; Chen et al. 2021; Balta et al. 2015). The gene discussed is ESM1; the disease is cardiovascular disorder.